MedPath

昆明赛诺制药股份有限公司

Ownership
-
Established
1998-06-24
Employees
-
Market Cap
-
Website
www.sainuozhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

54

NMPA:54

Drug Approvals

脑心舒口服液

Approval Number
国药准字Z53020149
Approval Date
Sep 30, 2020
NMPA

金红止痛消肿酊

Approval Number
国药准字Z20025404
Approval Date
May 5, 2020
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H53020139
Approval Date
May 4, 2020
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H53020233
Approval Date
May 4, 2020
NMPA

Paracetamol，Caffein,Atificial Cow-bezor and Chlorphenamine Maleate Capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H53021929
Approval Date
May 4, 2020
NMPA

Naproxen Capsules

Product Name
萘普生胶囊
Approval Number
国药准字H53020140
Approval Date
May 4, 2020
NMPA

Gentamycin Sulfate Tablets

Product Name
硫酸庆大霉素片
Approval Number
国药准字H53020213
Approval Date
May 4, 2020
NMPA

Rifmpicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H53020228
Approval Date
May 4, 2020
NMPA

Sulfadiazine Tablets

Product Name
磺胺嘧啶片
Approval Number
国药准字H53020209
Approval Date
May 4, 2020
NMPA

Naproxen Capsules

Product Name
萘普生胶囊
Approval Number
国药准字H53020141
Approval Date
May 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy